Web29 mar. 2024 · MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company. The Company and its subsidiaries are developing therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer and interventional cardiology, and peripheral vessel applications. The Company's portfolio of lead drug candidates is in ... Web22 mar. 2004 · Mar 22, 2004. The board of directors of Warwick, R.I.-based Exten Industries Inc. has voted to merge its subsidiary, MultiCell Technologies, into Exten. The …
MultiCell Technologies, Inc. (MCET) - Yahoo Finance
WebDoing Business As: MultiCell Company Description: MultiCell Technologies is working on multiple therapeutics, but still sells liver cells on the side to help pay the rent. It is … WebMultiCell Technologies, Inc. 68 Cumberland Street Suite 301 Woonsocket, RI 02895 United States 401-762-0045 Sector (s) : Healthcare Industry : Biotechnology Full Time … henry avenue
MultiCell Technologies Company Profile - Craft
WebMultiCell Technologies, Inc. (MCET) Other OTC - Other OTC Delayed Price. Currency in USD Follow 0.0000 0.0000 (0.00%) At close: 02:46PM EST Summary Company Insights … Web3 sept. 2015 · Drug Profile Lofepramine/phenylalanine - MultiCell Technologies Alternative Names: L-phenylalanine/Lofepramine; LAX-202; Lofepramine/L-phenylalanine; MCT-125; Phenylalanine/lofepramine Latest Information Update: 03 Sep 2015 Price : $50 * Buy Profile Adis is an information provider. We do not sell or distribute actual drugs. WebMost of Multicell Techs' value examination focuses on studying past and present price action to predict the probability of Multicell Techs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Multicell Techs' price. henry avb